Detalles de la búsqueda
1.
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial.
Biol Blood Marrow Transplant
; 25(3): 515-521, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30315941
2.
Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis.
Blood
; 129(7): 906-916, 2017 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28057639
3.
Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease Prophylaxis.
Biol Blood Marrow Transplant
; 24(3): 594-599, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29061535
4.
Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated Donors.
Biol Blood Marrow Transplant
; 24(6): 1203-1208, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29408506
5.
The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation.
J Immunol
; 196(3): 1070-80, 2016 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26712946
6.
Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 22(11): 1961-1967, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27478011
7.
Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantation.
Am J Hematol
; 91(9): 883-7, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27197602
Resultados
1 -
7
de 7
1
Próxima >
>>